1011. Sepsis and secondary hemophagocytic lymphohistiocytosis
Session: Poster Abstract Session: Bacteremia and Endocarditis
Friday, October 5, 2018
Room: S Poster Hall
  • 3rd copy Secondary Hemophagocytic Lymphohistiocytosis in patients with Sepsis (2).pdf (312.7 kB)
  • Sepsis and secondary hemophagocytic lymphohistiocytosis

    Background: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory condition diagnosed by HLH 2004 criteria. This criterion has common clinical and laboratory features with sepsis and tropical fevers but there is marked difference in management and outcome of these two entities. The study is conducted to know if there is any difference in the clinico-laboratory features, management, and outcome of sepsis with or without secondary HLH.

    Methods: This is a prospective observational study where patients presenting with sepsis and bicytopenia are included. The patients underwent relevant investigations according to 2004 HLH diagnostic criteria. The patients are divided into sepsis with or without HLH. The underlying etiology, treatment, and outcome of the two groups are analysed.

    Results: Fifty sepsis patients are included in the study, out of which 28 fulfilled the HLH diagnostic criteria which comprised of 18 men and 10 women. The etiology were bacterial (3 enteric fever, 3 tuberculosis, 2 scrub typhus, 1 staphylococcal aureus ), viral (1 dengue fever, 2 HIV, 2 encephalitis), fungal (1 aspergillosis, 1 mucormycosis, 2 others), parasites (3 malaria, 1 leishmania ) malignancy (2 hodgkin lymphoma, 1 non hodgkins lymphoma), and unknown etiology in 6 patients, with >1 etiology in 3 patients (figure 2). The percentage of each criterion fulfilled in both groups is given in figure 1 showing an increased occurrence of splenomegaly, low NK cell activity, hypertriglyceridemia in HLH patients. Steroids along with supportive treatment was given to 53 % and etoposide was added in 7 %. Treatment for underlying etiology alone without immunosuppressive treatment was given in 39%. The mortality in those with HLH vs without HLH was 42% and 31% respectively. The median duration of hospital stay was 18 and 36 days in HLH and without HLH group respectively.

    Conclusion: HLH should be suspected in sepsis patients with bicytopenia specially in tropical fevers. There is increased mortality if the sepsis patients fulfil HLH criteria. Early diagnosis and management is of paramount importance. 

    Figure 1


    Figure 2

    Farhan Fazal, MBBS, MD1, Naveet Wig, MD2, Manish Soneja, MD Medicine3, Dipendra K Mitra, MD2, Sk Panda, MD2, Gita Satpathy, MD2, Naval Kishore Vikram, MD2, R.M Pandey, MD2 and P.K Chaturvedi, MD2, (1)Medicine, All India Institute of Medical Science (AIIMS), New Delhi, India, (2)All India Institute of Medical Science (AIIMS), New Delhi, India, (3)Medicine, All India Institute of Medical Science (AIIMS),New Delhi, NEW DELHI, India


    F. Fazal, None

    N. Wig, None

    M. Soneja, None

    D. K. Mitra, None

    S. Panda, None

    G. Satpathy, None

    N. K. Vikram, None

    R. M. Pandey, None

    P. K. Chaturvedi, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.